Procter & Gamble Health standalone net profit rises 31.40% in the March 2025 quarter
Net profit of Procter & Gamble Health rose 31.40% to Rs 61.18 crore in the quarter ended March 2025 as against Rs 46.56 crore during the previous quarter ended March 2024. Sales rose 23.17% to Rs 310.99 crore in the quarter ended March 2025 as against Rs 252.48 crore during the previous quarter ended March 2024.
| Particulars | Quarter Ended | ||
| Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 310.99 | 252.48 | 23 |
| OPM % | 26.02 | 26.71 | - |
| PBDT | 83.90 | 69.56 | 21 |
| PBT | 78.53 | 62.72 | 25 |
| NP | 61.18 | 46.56 | 31 |